About This Expo
The World Orphan Drug Congress USA, organized by Terrapinn, is a premier annual event dedicated to advancing therapies for rare diseases. As North America's significant gathering for the pharmaceutical and biotech sectors, it addresses the unique challenges in developing, regulating, and commercializing orphan drugs. The congress covers the entire lifecycle from discovery to patient access, fostering critical dialogues among industry leaders, patient advocacy groups, and regulatory bodies. Attendees gain insights into the rapidly evolving regulatory landscape, strategies for optimizing clinical trials, and leveraging advanced technologies like AI. It offers a holistic view of the rare disease landscape, integrating technical sessions on compliance with strategic discussions on market access. Attracting a diverse audience, including CSOs, regulatory VPs, and patient advocacy liaisons, the event provides unparalleled networking, expert-led sessions, and showcases the latest innovations. It's an essential platform for professionals committed to accelerating the development and delivery of life-saving therapies and bridging the gap for innovative small biotech firms.